Astrana Health Stock Today
| ASTH Stock | 32.03 1.43 4.67% |
PerformanceVery Weak
| Odds Of DistressLow
|
Astrana Health is trading at 32.03 as of the 19th of March 2025. This is a 4.67 percent increase since the beginning of the trading day. The stock's open price was 30.6. Astrana Health has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 19th of December 2024 and ending today, the 19th of March 2025. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 13th of January 2000 | Category Healthcare | Classification Health Care |
Astrana Health is entity of United States. It is traded as Stock on NASDAQ exchange. The company has 56.25 M outstanding shares of which 1.87 M shares are presently shorted by private and institutional investors with about 4.77 trading days to cover. More on Astrana Health
Moving together with Astrana Stock
| 0.87 | DH | Definitive Healthcare Buyout Trend | PairCorr |
Moving against Astrana Stock
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
Astrana Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| President CEO | Brandon Sim | ||||
| Business Concentration | Health Care Providers & Services, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Health Care, SP Small-Cap 600, Health Care, Health Care Providers & Services, Health Care Equipment & Services, Health Care (View all Sectors) | ||||
| Average Analyst Recommendation | |||||
Debt LevelsAstrana Health can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Astrana Health's financial leverage. It provides some insight into what part of Astrana Health's total assets is financed by creditors.
| |||||
Astrana Health (ASTH) is traded on NASDAQ Exchange in USA. It is located in 1668 S. Garfield Avenue, Alhambra, CA, United States, 91801 and employs 1,900 people. Astrana Health is listed under Health Care Providers & Services category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.72 B. Astrana Health conducts business under Health Care Providers & Services sector and is part of Health Care industry. The entity has 56.25 M outstanding shares of which 1.87 M shares are presently shorted by private and institutional investors with about 4.77 trading days to cover.
Astrana Health generates positive cash flow from operations, but has no cash available
Check Astrana Health Probability Of Bankruptcy
Ownership AllocationAstrana Health holds a total of 56.25 Million outstanding shares. Over half of Astrana Health's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Astrana Ownership Details
Astrana Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Morgan Stanley - Brokerage Accounts | 2024-12-31 | 412.4 K | |
| Goldman Sachs Group Inc | 2024-12-31 | 362.2 K | |
| Loomis, Sayles & Company Lp | 2024-12-31 | 319.7 K | |
| Bank Of New York Mellon Corp | 2024-12-31 | 266.9 K | |
| Royal Bank Of Canada | 2024-12-31 | 261.6 K | |
| Amvescap Plc. | 2024-12-31 | 258.5 K | |
| Royce & Associates, Lp | 2024-12-31 | 255.6 K | |
| Atria Wealth Solutions, Inc. | 2024-12-31 | 237.4 K | |
| Renaissance Technologies Corp | 2024-12-31 | 217.9 K | |
| Blackrock Inc | 2024-12-31 | 6.4 M | |
| Vanguard Group Inc | 2024-12-31 | 4.7 M |
Astrana Health Historical Income Statement
Astrana Stock Against Markets
Astrana Health Corporate Management
| WaiChow MD | Chief Officer | Profile | |
| Rita Pew | Vice Operations | Profile | |
| Carlos MD | Chief Texas | Profile | |
| CPA CGMA | Chief Officer | Profile |
Already Invested in Astrana Health?
The danger of trading Astrana Health is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Astrana Health is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Astrana Health. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Astrana Health is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Astrana Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Astrana Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Astrana Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Astrana Health Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Astrana Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more detail on how to invest in Astrana Stock please use our How to Invest in Astrana Health guide.You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Astrana Health. If investors know Astrana will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Astrana Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.30) | Earnings Share 0.9 | Revenue Per Share | Quarterly Revenue Growth 0.884 | Return On Assets |
The market value of Astrana Health is measured differently than its book value, which is the value of Astrana that is recorded on the company's balance sheet. Investors also form their own opinion of Astrana Health's value that differs from its market value or its book value, called intrinsic value, which is Astrana Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Astrana Health's market value can be influenced by many factors that don't directly affect Astrana Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Astrana Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Astrana Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Astrana Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.